Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice.
Carnero Contentti E, Rojas JI, Cristiano E, Marques VD, Flores-Rivera J, Lana-Peixoto M, Navas C, Papais-Alvarenga R, Sato DK, Soto de Castillo I, Correale J. Carnero Contentti E, et al. Among authors: papais alvarenga r. Mult Scler Relat Disord. 2020 Oct;45:102428. doi: 10.1016/j.msard.2020.102428. Epub 2020 Jul 29. Mult Scler Relat Disord. 2020. PMID: 32763842 Review.
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice[Mult Scler Relat Disord. 2020 Oct;45:102428].
Carnero Contentti E, Rojas JI, Cristiano E, Daccach Marques V, Flores-Rivera J, Lana-Peixoto M, Carlos N, Papais-Alvarenga R, Sato DK, Soto de Castillo I, Correale J. Carnero Contentti E, et al. Among authors: papais alvarenga r. Mult Scler Relat Disord. 2021 Jul;52:103026. doi: 10.1016/j.msard.2021.103026. Epub 2021 May 25. Mult Scler Relat Disord. 2021. PMID: 34044260 No abstract available.
The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Papais-Alvarenga RM, Vasconcelos CC, Alves-Leon SV, Batista E, Santos CM, Camargo SM, Godoy M, Lacativa MC, Lorenti M, Damasceno B, Damasceno A, Brum D, Barreira AA, Guimarães Rocha MS, Alvarenga H, Tilbery CP. Papais-Alvarenga RM, et al. Mult Scler. 2014 Mar;20(3):374-81. doi: 10.1177/1352458513495580. Epub 2013 Aug 22. Mult Scler. 2014. PMID: 23970504
Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM, Araújo ACRAE, Nascimento ACB, Araujo NEC, Meneguette NS, Neri VC, Papais Alvarenga M, Filho HA, Barros PO, Bento CA, Schmidt SL, Vasconcelos CCF, Alvarenga MP. Papais Alvarenga RM, et al. Mult Scler Relat Disord. 2020 Jul;42:102082. doi: 10.1016/j.msard.2020.102082. Epub 2020 Apr 13. Mult Scler Relat Disord. 2020. PMID: 32361664
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years.
Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Brito Ferreira ML, Finkelsztejn A, Gomes S, Magno Goncalves MV, Moraes Machado MI, Marques VD, Cunha Matta AP, Papais-Alvarenga RM, Apostolos Pereira SL, Tauil CB. Fragoso YD, et al. Pediatr Neurol. 2015 Aug;53(2):166-8. doi: 10.1016/j.pediatrneurol.2015.03.024. Epub 2015 Apr 2. Pediatr Neurol. 2015. PMID: 26026897
Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?
Papais-Alvarenga RM, Neri VC, de Araújo E Araújo ACR, da Silva EB, Alvarenga MP, Pereira ABCNDG, Brandão AC, Alvarenga-Filho H, Guimarães MPM, Marignier R, Barros PO, Bento CM, Vasconcelos CCF. Papais-Alvarenga RM, et al. Mult Scler Relat Disord. 2018 Oct;25:87-94. doi: 10.1016/j.msard.2018.07.026. Epub 2018 Jul 17. Mult Scler Relat Disord. 2018. PMID: 30056361
Normative values of the Brief Repeatable Battery of Neuropsychological Tests in a Brazilian population sample: discrete and regression-based norms.
Damasceno A, Amaral JMSDS, Barreira AA, Becker J, Callegaro D, Campanholo KR, Damasceno LA, Diniz DS, Fragoso YD, Franco PS, Finkelsztejn A, Jorge FMH, Lana-Peixoto MA, Matta APDC, Mendonça ACR, Noal J, Paes RA, Papais-Alvarenga RM, Pereira AG, Spedo CT, Damasceno BP. Damasceno A, et al. Among authors: papais alvarenga rm. Arq Neuropsiquiatr. 2018 Mar;76(3):163-169. doi: 10.1590/0004-282x20180006. Arq Neuropsiquiatr. 2018. PMID: 29809236 Free article.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Papais-Alvarenga RM, Vasconcelos CC, Carra A, de Castillo IS, Florentin S, Diaz de Bedoya FH, Mandler R, de Siervi LC, Pimentel ML, Alvarenga MP, Alvarenga MP, Grzesiuk AK, Gama Pereira AB, Gomes Neto AP, Velasquez C, Soublette C, Fleitas CV, Diniz DS, Armas E, Batista E, Hernandez F, Pereira FF, Siqueira HH, Cabeça H, Sanchez J, Brooks JB, Gonçalves MV, Barroso MC, Ravelo ME, Castillo MC, Ferreira ML, Rocha MS, Parolin MK, Molina O, Marinho PB, Christo PP, Brant de Souza R, Pessanha Neto S, Camargo SM, Machado SC, Neri VC, Fragoso YD, Alvarenga H, Thuler LC. Papais-Alvarenga RM, et al. PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015. PLoS One. 2015. PMID: 26222205 Free PMC article. Clinical Trial.
39 results